Trial Profile
A retrospective study evaluating treatment patterns and medication adherence in patients with multiple myeloma treated with panobinostat in the US
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2017
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 26 May 2017 New trial record
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research